Certain Common Stock of Windtree Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 5-JUL-2023. These Common Stock will be under lockup for 76 days starting from 20-APR-2023 to 5-JUL-2023.

Details:
Each of officers, directors and each of their respective affiliates and associated partners, and certain affiliated stockholders have agreed with the underwriters to be subject to a lock-up period of 75 days following the date of the prospectus. This means that, during the applicable lock-up period, such persons may not offer for sale, contract to sell, sell, distribute, grant any option, right or warrant to purchase, pledge, hypothecate or otherwise dispose of, directly or indirectly, any shares of common stock or any securities convertible into, or exercisable or exchangeable for, shares of common stock. Certain limited transfers are permitted during the lock-up period if the transferee agrees to these lock-up restrictions.